Vibrio Cholerae's
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Hemolysin from Escherichia Coli Uses Endogenous Amplification Through P2X Receptor Activation to Induce Hemolysis
␣-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis Marianne Skalsa, Niklas R. Jorgensenb, Jens Leipzigera, and Helle A. Praetoriusa,1 aDepartment of Physiology and Biophysics, Water and Salt Research Center, Aarhus University, Ole Worms Alle 1160, 8000 Aarhus C, Denmark; and bDepartment for Clinical Biochemistry, Roskilde Hospital, Koegevej 3-7, 4000 Roskilde, Denmark Edited by Sucharit Bhakdi, University of Mainz, Mainz, Germany, and accepted by the Editorial Board January 6, 2009 (received for review July 22, 2008) Escherichia coli is the dominant facultative bacterium in the normal and are referred to as P2X1–7. All P2X receptors are permeable to intestinal flora. E. coli is, however, also responsible for the majority small monovalent cations and some have significant calcium per- of serious extraintestinal infections. There are distinct serotypical meability (11). Here we show that human, murine, and equine differences between facultative and invasive E. coli strains. Inva- erythrocytes use a combination of P2X1 and P2X7 receptor acti- sive strains frequently produce virulence factors such as ␣-hemolysin vation for full HlyA-induced hemolysis to occur. This is particularly (HlyA), which causes hemolysis by forming pores in the erythrocyte interesting, as prolonged stimulation of P2X7 receptors are known membrane. The present study reveals that this pore formation to increase the plasma membrane permeability to an extent that triggers purinergic receptor activation to mediate the full hemo- eventually leads to lysis of certain cells (12). In macrophages it has lytic action. Non-selective ATP-receptor (P2) antagonists (PPADS, been shown that pannexin1, a recently discovered pore-forming suramin) and ATP scavengers (apyrase, hexokinase) concentration protein, is required for this increment in permeability (12, 13). -
Disposal of Toxin Heptamers by Extracellular Vesicle Formation and Lysosomal Degradation
toxins Article Major Determinants of Airway Epithelial Cell Sensitivity to S. aureus Alpha-Toxin: Disposal of Toxin Heptamers by Extracellular Vesicle Formation and Lysosomal Degradation Nils Möller 1,* , Sabine Ziesemer 1, Christian Hentschker 2, Uwe Völker 2 and Jan-Peter Hildebrandt 1 1 Animal Physiology and Biochemistry, University of Greifswald, Felix Hausdorff-Strasse 1, D-17489 Greifswald, Germany; [email protected] (S.Z.); [email protected] (J.-P.H.) 2 Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Felix Hausdorff-Strasse 8, D-17475 Greifswald, Germany; [email protected] (C.H.); [email protected] (U.V.) * Correspondence: [email protected] Abstract: Alpha-toxin is a major virulence factor of Staphylococcus aureus. Monomer binding to host cell membranes results in the formation of heptameric transmembrane pores. Among human model airway epithelial cell lines, A549 cells were most sensitive toward the toxin followed by 16HBE14o- and S9 cells. In this study we investigated the processes of internalization of pore-containing plasma membrane areas as well as potential pathways for heptamer degradation (lysosomal, proteasomal) or disposal (formation of exosomes/micro-vesicles). The abundance of toxin heptamers upon applying an alpha-toxin pulse to the cells declined both in extracts of whole cells and of cellular membranes of Citation: Möller, N.; Ziesemer, S.; S9 cells, but not in those of 16HBE14o- or A549 cells. Comparisons of heptamer degradation rates un- Hentschker, C.; Völker, U.; der inhibition of lysosomal or proteasomal degradation revealed that an important route of heptamer Hildebrandt, J.-P. -
Vibrio Cholerae Mirella Lo Scrudato, Sandrine Borgeaud and Melanie Blokesch*
Lo Scrudato et al. BMC Microbiology (2014) 14:327 DOI 10.1186/s12866-014-0327-y RESEARCH ARTICLE Open Access Regulatory elements involved in the expression of competence genes in naturally transformable Vibrio cholerae Mirella Lo Scrudato, Sandrine Borgeaud and Melanie Blokesch* Abstract Background: The human pathogen Vibrio cholerae normally enters the developmental program of natural competence for transformation after colonizing chitinous surfaces. Natural competence is regulated by at least three pathways in this organism: chitin sensing/degradation, quorum sensing and carbon catabolite repression (CCR). The cyclic adenosine monophosphate (cAMP) receptor protein CRP, which is the global regulator of CCR, binds to regulatory DNA elements called CRP sites when in complex with cAMP. Previous studies in Haemophilus influenzae suggested that the CRP protein binds competence-specific CRP-S sites under competence-inducing conditions, most likely in concert with the master regulator of transformation Sxy/TfoX. Results: In this study, we investigated the regulation of the competence genes qstR and comEA as an example of the complex process that controls competence gene activation in V. cholerae. We identified previously unrecognized putative CRP-S sites upstream of both genes. Deletion of these motifs significantly impaired natural transformability. Moreover, site-directed mutagenesis of these sites resulted in altered gene expression. This altered gene expression also correlated directly with protein levels, bacterial capacity for DNA uptake, and natural transformability. Conclusions: Based on the data provided in this study we suggest that the identified sites are important for the expression of the competence genes qstR and comEA and therefore for natural transformability of V. cholerae even though the motifs might not reflect bona fide CRP-S sites. -
Transport Proteins Promoting Escherichia Coli Pathogenesis
Microbial Pathogenesis 71-72 (2014) 41e55 Contents lists available at ScienceDirect Microbial Pathogenesis journal homepage: www.elsevier.com/locate/micpath Transport proteins promoting Escherichia coli pathogenesis Fengyi Tang 1, Milton H. Saier Jr. * Department of Molecular Biology, Division of Biological Sciences, University of California at San Diego, La Jolla, CA 92093-0116, USA article info abstract Article history: Escherichia coli is a genetically diverse species infecting hundreds of millions of people worldwide Received 26 November 2013 annually. We examined seven well-characterized E. coli pathogens causing urinary tract infections, Received in revised form gastroenteritis, pyelonephritis and haemorrhagic colitis. Their transport proteins were identified and 19 March 2014 compared with each other and a non-pathogenic E. coli K12 strain to identify transport proteins related Accepted 20 March 2014 to pathogenesis. Each pathogen possesses a unique set of protein secretion systems for export to the cell Available online 18 April 2014 surface or for injecting effector proteins into host cells. Pathogens have increased numbers of iron siderophore receptors and ABC iron uptake transporters, but the numbers and types of low-affinity Keywords: Escherichia coli secondary iron carriers were uniform in all strains. The presence of outer membrane iron complex re- fi Pathogenesis ceptors and high-af nity ABC iron uptake systems correlated, suggesting co-evolution. Each pathovar Transporters encodes a different set of pore-forming toxins and virulence-related outer membrane proteins lacking in Toxins K12. Intracellular pathogens proved to have a characteristically distinctive set of nutrient uptake porters, Iron acquisition different from those of extracellular pathogens. The results presented in this report provide information Intra vs. -
N-Glycan Trimming in the ER and Calnexin/Calreticulin Cycle
Neurotransmitter receptorsGABA and A postsynapticreceptor activation signal transmission Ligand-gated ion channel transport GABAGABA Areceptor receptor alpha-5 alpha-1/beta-1/gamma-2 subunit GABA A receptor alpha-2/beta-2/gamma-2GABA receptor alpha-4 subunit GABAGABA receptor A receptor beta-3 subunitalpha-6/beta-2/gamma-2 GABA-AGABA receptor; A receptor alpha-1/beta-2/gamma-2GABA receptoralpha-3/beta-2/gamma-2 alpha-3 subunit GABA-A GABAreceptor; receptor benzodiazepine alpha-6 subunit site GABA-AGABA-A receptor; receptor; GABA-A anion site channel (alpha1/beta2 interface) GABA-A receptor;GABA alpha-6/beta-3/gamma-2 receptor beta-2 subunit GABAGABA receptorGABA-A receptor alpha-2receptor; alpha-1 subunit agonist subunit GABA site Serotonin 3a (5-HT3a) receptor GABA receptorGABA-C rho-1 subunitreceptor GlycineSerotonin receptor subunit3 (5-HT3) alpha-1 receptor GABA receptor rho-2 subunit GlycineGlycine receptor receptor subunit subunit alpha-2 alpha-3 Ca2+ activated K+ channels Metabolism of ingested SeMet, Sec, MeSec into H2Se SmallIntermediateSmall conductance conductance conductance calcium-activated calcium-activated calcium-activated potassium potassium potassiumchannel channel protein channel protein 2 protein 1 4 Small conductance calcium-activatedCalcium-activated potassium potassium channel alpha/beta channel 1 protein 3 Calcium-activated potassiumHistamine channel subunit alpha-1 N-methyltransferase Neuraminidase Pyrimidine biosynthesis Nicotinamide N-methyltransferase Adenosylhomocysteinase PolymerasePolymeraseHistidine basic -
Membrane Topology of the C. Elegans SEL-12 Presenilin
Neuron, Vol. 17, 1015±1021, November, 1996, Copyright 1996 by Cell Press Membrane Topology of the C. elegans SEL-12 Presenilin Xiajun Li* and Iva Greenwald*²³ [this issue of Neuron]; Thinakaran et al., 1996). In the *Integrated Program in Cellular, Molecular, Discussion, we examine the amino acid sequence in and Biophysical Studies light of the deduced topology. ² Department of Biochemistry and Molecular Biophysics Results ³ Howard Hughes Medical Institute Columbia University Sequence analysis suggests that SEL-12 and human College of Physicians and Surgeons presenilins have ten hydrophobic regions (Figure 1). In New York, New York 10032 this study, we provide evidence that a total of eight of these hydrophobic regions function as transmembrane domains in vivo. Below, we use the term ªhydrophobic Summary regionº to designate a segment of the protein with the potential to span the membrane, as inferred by hydro- Mutant presenilins cause Alzheimer's disease. Pre- phobicity analysis, and ªtransmembrane domainº to senilins have multiple hydrophobic regions that could designate a hydrophobic region that our data suggest theoretically span a membrane, and a knowledge of actually spans a membrane. the membrane topology is crucial for deducing the mechanism of presenilin function. By analyzing the activity of b-galactosidase hybrid proteins expressed Strategy in C. elegans, we show that the C. elegans SEL-12 We constructed transgenes encoding hybrid SEL- presenilin has eight transmembrane domains and that 12::LacZ proteins, in which LacZ was placed after each there is a cleavage site after the sixth transmembrane of ten hydrophobic regions identified by hydrophobicity domain. We examine the presenilin sequence in view analysis (see Figure 1). -
Molecular Insights Into Vibrio Cholerae's Intra-Amoebal Host
bioRxiv preprint doi: https://doi.org/10.1101/235598; this version posted December 18, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Molecular insights into Vibrio cholerae’s intra-amoebal 2 host-pathogen interactions 3 4 5 Charles Van der Henst1, Stéphanie Clerc2, Sandrine Stutzmann1, Candice Stoudmann1, 6 Tiziana Scrignari1, Catherine Maclachlan2, Graham Knott2 & Melanie Blokesch1* 7 1Laboratory of Molecular Microbiology, Global Health Institute, School of Life Sciences, 8 Station 19, EPFL-SV-UPBLO, Swiss Federal Institute of Technology Lausanne (Ecole 9 Polytechnique Fédérale de Lausanne; EPFL), CH-1015 Lausanne, Switzerland. 10 2Bioelectron Microscopy Core Facility (BioEM), School of Life Sciences, Station 19, EPFL- 11 SV-PTBIOEM, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland. 12 *Correspondence to: [email protected] 13 14 Vibrio cholerae, which causes the diarrheal disease cholera, is a species of bacteria 15 commonly found in aquatic habitats. Within such environments, the bacterium must defend 16 itself against predatory protozoan grazers. Amoebae are prominent grazers, with 17 Acanthamoeba castellanii being one of the best-studied aquatic amoebae. We previously 18 showed that V. cholerae resists digestion by A. castellanii and establishes a replication niche 19 within the host’s osmoregulatory organelle. In this study, we deciphered the molecular 20 mechanisms involved in the maintenance of V. cholerae’s intra-amoebal replication niche 21 and its ultimate escape from the succumbed host. -
SPEAKER BIOS CAREER TRANSITIONING EPFL, SV Building, Lausanne 7 October 2015
SPEAKER BIOS CAREER TRANSITIONING EPFL, SV Building, Lausanne 7 October 2015 1. MELANIE BLOKESCH: Tenure-track Assistant Professor, EPFL Melanie Blokesch holds a PhD degree from the Ludwig-Maximilians-University in Munich (Germany). From 2005 to 2009 she worked as a postdoctoral fellow at the Division of Infectious Diseases and Geographic Medicine and the Department of Microbiology & Immunology at Stanford University (USA). In 2009 Dr. Blokesch was appointed as tenure-track assistant professor within the School of Life Sciences at the Swiss Federal Institute of Technology in Lausanne (EPFL), Switzerland, where she is currently the head of the Laboratory of Molecular Microbiology. The research of the Blokesch laboratory primarily focuses on how bacteria evolve in natural environments to emerge as human pathogens and how horizontal gene transfer contributes to such pathogen emergence. The model organism for these studies is the causative agent of the devastating diarrheal disease cholera. The methodologies used in Dr. Blokesch’s group include microbiology, bacterial genetics and genomics, basic biochemistry, and cellular biology-based microscopy imaging. 2. TOBY ENBERG: Executive VP, Coulter Partners Toby has over 19 years of experience across a range of industries, having worked both as a management consultant and in leadership roles within multinational corporations, including Reuters, Novartis and a privately-held medical technology company. Toby has been working in executive search for the past 4 years, specializing in international, senior roles for the life sciences industry, across the value chain. A Swedish and Swiss national, he sees himself as a global citizen and has a passion for working with people across cultures and regions. -
Tailored Liposomal Nanotraps for the Treatment of Streptococcal Infections
Besançon et al. J Nanobiotechnol (2021) 19:46 https://doi.org/10.1186/s12951-021-00775-x Journal of Nanobiotechnology RESEARCH Open Access Tailored liposomal nanotraps for the treatment of Streptococcal infections Hervé Besançon1 , Viktoriia Babiychuk1, Yu Larpin1, René Köfel1, Dominik Schittny1, Lara Brockhus1, Lucy J. Hathaway2, Parham Sendi2, Annette Draeger1^ and Eduard Babiychuk1* Abstract Background: Streptococcal infections are associated with life-threatening pneumonia and sepsis. The rise in anti- biotic resistance calls for novel approaches to treat bacterial diseases. Anti-virulence strategies promote a natural way of pathogen clearance by eliminating the advantage provided to bacteria by their virulence factors. In contrast to antibiotics, anti-virulence agents are less likely to exert selective evolutionary pressure, which is a prerequisite for the development of drug resistance. As part of their virulence mechanism, many bacterial pathogens secrete cytol- ytic exotoxins (hemolysins) that destroy the host cell by destabilizing their plasma membrane. Liposomal nanotraps, mimicking plasmalemmal structures of host cells that are specifcally targeted by bacterial toxins are being developed in order to neutralize-by competitive sequestration-numerous exotoxins. Results: In this study, the liposomal nanotrap technology is further developed to simultaneously neutralize the whole palette of cytolysins produced by Streptococcus pneumoniae, Streptococcus pyogenes and Streptococcus dys- galactiae subspecies equisimilis-pathogens that -
Genomic Plasticity of the Causative Agent of Melioidosis, Burkholderia Pseudomallei
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei Matthew T. G. Holdena, Richard W. Titballb,c, Sharon J. Peacockd,e, Ana M. Cerden˜ o-Ta´ rragaa, Timothy Atkinsb, Lisa C. Crossmana, Tyrone Pittf, Carol Churchera, Karen Mungalla, Stephen D. Bentleya, Mohammed Sebaihiaa, Nicholas R. Thomsona, Nathalie Basona, Ifor R. Beachamg, Karen Brooksa, Katherine A. Brownh, Nat F. Browng, Greg L. Challisi, Inna Cherevacha, Tracy Chillingwortha, Ann Cronina, Ben Crossetth, Paul Davisa, David DeShazerj, Theresa Feltwella, Audrey Frasera, Zahra Hancea, Heidi Hausera, Simon Holroyda, Kay Jagelsa, Karen E. Keithh, Mark Maddisona, Sharon Moulea, Claire Pricea, Michael A. Quaila, Ester Rabbinowitscha, Kim Rutherforda, Mandy Sandersa, Mark Simmondsa, Sirirurg Songsivilaik, Kim Stevensa, Sarinna Tumapae, Monkgol Vesaratchaveste, Sally Whiteheada, Corin Yeatsa, Bart G. Barrella, Petra C. F. Oystonb, and Julian Parkhilla,l aWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom; bDefence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, United Kingdom; cDepartment of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom; dNuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom; eFaculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand; fLaboratory of Hospital Infection, Division of Nosocomial Infection Prevention and Control, Central Public Health Laboratory, London NW9 5HT, United Kingdom; gSchool of Health Science, Griffith University, Gold Coast, Queensland 9726, Australia; hDepartment of Biological Sciences, Centre for Molecular Microbiology and Infection, Flowers Building, Imperial College, London SW7 2AZ, United Kingdom; iDepartment of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom; jU.S. -
Hemolysin CB with Human C5a Receptors Γ Valentine Leukocidin
Differential Interaction of the Staphylococcal Toxins Panton−Valentine Leukocidin and γ -Hemolysin CB with Human C5a Receptors This information is current as András N. Spaan, Ariën Schiepers, Carla J. C. de Haas, of October 1, 2021. Davy D. J. J. van Hooijdonk, Cédric Badiou, Hugues Contamin, François Vandenesch, Gérard Lina, Norma P. Gerard, Craig Gerard, Kok P. M. van Kessel, Thomas Henry and Jos A. G. van Strijp J Immunol 2015; 195:1034-1043; Prepublished online 19 June 2015; Downloaded from doi: 10.4049/jimmunol.1500604 http://www.jimmunol.org/content/195/3/1034 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2015/06/19/jimmunol.150060 Material 4.DCSupplemental References This article cites 46 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/195/3/1034.full#ref-list-1 Why The JI? Submit online. by guest on October 1, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. -
CURRICULUM VITAE Melanie Blokesch
Swiss Federal Institute of Technology Lausanne (EPFL) Global Health Institute, School of Life Sciences Laboratory of Molecular Microbiology Melanie Blokesch Phone: +41 21 693 06 53 Full Professor Email: [email protected] EPFL-SV-UPBLO, Station 19 Secretary: +41 21 693 7232 CH-1015 Lausanne, Switzerland (Marisa Marciano Wynn) https://www.epfl.ch/labs/blokesch-lab/ Orcid ID: 0000-0002-7024-1489 Researcher ID: A-4057-2013 CURRICULUM VITAE Melanie Blokesch PROFESSIONAL EXPERIENCE AND EDUCATION June 2021- Full Professor, Global Health Institute, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland 2016-2021 Associate Professor (tenured), Global Health Institute, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland 2009-2016 Tenure-track Assistant Professor, Global Health Institute, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland 2005-2009 Postdoctoral Fellow, Division of Infectious Diseases and Geographic Medicine & Department of Microbiology & Immunology, Stanford University, CA, USA Mentor: Prof. Dr. Gary Schoolnik 2000-2004 PhD in Biology (doctoral degree/Dr. rer. nat.); summa cum laude; with highest distinction Department Biology I, Microbiology, Ludwig-Maximilians-University, Munich, Germany Thesis advisor: Prof. Dr. Dr. h.c. August Böck 1995-2000 Diploma in Biology, Microbiology (major), Genetics, Medical Microbiology, Immunology (minors), Ludwig-Maximilians-University, Munich, Germany; Diploma thesis at the